首页 > 最新文献

Pediatric Gastroenterology, Hepatology & Nutrition最新文献

英文 中文
Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease. 韩国儿科炎症性肠病患者未分类的炎症性肠病患病率(根据修订后的波尔图标准估算)。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.206
Sung Hee Lee, Minsoo Shin, Seo Hee Kim, Seong Pyo Kim, Hyung-Jin Yoon, Yangsoon Park, Jaemoon Koh, Seak Hee Oh, Jae Sung Ko, Jin Soo Moon, Kyung Mo Kim

Purpose: Few studies have reported the prevalence of inflammatory bowel disease unclassified (IBDU) among Korean pediatric IBD (PIBD) population. To address this gap, we used two tertiary centers and nationwide population-based healthcare administrative data to estimate the prevalence of Korean pediatric IBDU at the time of diagnosis.

Methods: We identified 136 patients aged 2-17 years with newly diagnosed IBD (94 Crohn's disease [CD] and 42 ulcerative colitis [UC]) from two tertiary centers in Korea between 2005 and 2017. We reclassified these 136 patients using the revised Porto criteria. To estimate the population-based prevalence, we analyzed Korean administrative healthcare data between 2005 and 2016, which revealed 3,650 IBD patients, including 2,538 CD and 1,112 UC. By extrapolating the reclassified results to a population-based dataset, we estimated the prevalence of PIBD subtypes.

Results: Among the 94 CD, the original diagnosis remained unchanged in 93 (98.9%), while the diagnosis of one (1.1%) patient was changed to IBDU. Among the 42 UC, the original diagnosis remained unchanged in 13 (31.0%), while the diagnoses in 11 (26.2%), 17 (40.5%), and one (2.4%) patient changed to atypical UC, IBDU, and CD, respectively. The estimated prevalences of CD, UC, atypical UC, and IBDU in the Korean population were 69.5%, 9.4%, 8.0%, and 13.1%, respectively.

Conclusion: This study is the first in Korea to estimate the prevalence of pediatric IBDU. This prevalence (13.1%) aligns with findings from Western studies. Large-scale prospective multicenter studies on PIBDU are required to examine the clinical features and outcomes of this condition.

研究目的很少有研究报道韩国儿科IBD(PIBD)人群中未分类炎症性肠病(IBDU)的患病率。为了填补这一空白,我们利用两家三级医疗中心和全国范围内基于人口的医疗保健管理数据来估算韩国儿科 IBDU 在诊断时的患病率:2005年至2017年期间,我们从韩国两家三级医疗中心确定了136名2-17岁新诊断为IBD的患者(94名克罗恩病[CD]患者和42名溃疡性结肠炎[UC]患者)。我们采用修订后的波尔图标准对这 136 名患者进行了重新分类。为了估算基于人群的患病率,我们分析了 2005 年至 2016 年间韩国的行政医疗数据,结果显示有 3,650 名 IBD 患者,其中包括 2,538 名 CD 患者和 1,112 名 UC 患者。通过将重新分类的结果推断到基于人群的数据集,我们估算出了PIBD亚型的患病率:结果:在 94 名 CD 患者中,93 人(98.9%)的原始诊断保持不变,1 人(1.1%)的诊断改为 IBDU。在 42 例 UC 患者中,13 例(31.0%)的原始诊断保持不变,而 11 例(26.2%)、17 例(40.5%)和 1 例(2.4%)患者的诊断分别变更为非典型 UC、IBDU 和 CD。据估计,CD、UC、非典型 UC 和 IBDU 在韩国人群中的患病率分别为 69.5%、9.4%、8.0% 和 13.1%:这项研究是韩国首次估算小儿 IBDU 患病率。结论:这项研究是韩国首次估算小儿 IBDU 患病率,其患病率(13.1%)与西方研究结果一致。需要对 PIBDU 进行大规模的前瞻性多中心研究,以了解这种疾病的临床特征和预后。
{"title":"Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease.","authors":"Sung Hee Lee, Minsoo Shin, Seo Hee Kim, Seong Pyo Kim, Hyung-Jin Yoon, Yangsoon Park, Jaemoon Koh, Seak Hee Oh, Jae Sung Ko, Jin Soo Moon, Kyung Mo Kim","doi":"10.5223/pghn.2024.27.4.206","DOIUrl":"10.5223/pghn.2024.27.4.206","url":null,"abstract":"<p><strong>Purpose: </strong>Few studies have reported the prevalence of inflammatory bowel disease unclassified (IBDU) among Korean pediatric IBD (PIBD) population. To address this gap, we used two tertiary centers and nationwide population-based healthcare administrative data to estimate the prevalence of Korean pediatric IBDU at the time of diagnosis.</p><p><strong>Methods: </strong>We identified 136 patients aged 2-17 years with newly diagnosed IBD (94 Crohn's disease [CD] and 42 ulcerative colitis [UC]) from two tertiary centers in Korea between 2005 and 2017. We reclassified these 136 patients using the revised Porto criteria. To estimate the population-based prevalence, we analyzed Korean administrative healthcare data between 2005 and 2016, which revealed 3,650 IBD patients, including 2,538 CD and 1,112 UC. By extrapolating the reclassified results to a population-based dataset, we estimated the prevalence of PIBD subtypes.</p><p><strong>Results: </strong>Among the 94 CD, the original diagnosis remained unchanged in 93 (98.9%), while the diagnosis of one (1.1%) patient was changed to IBDU. Among the 42 UC, the original diagnosis remained unchanged in 13 (31.0%), while the diagnoses in 11 (26.2%), 17 (40.5%), and one (2.4%) patient changed to atypical UC, IBDU, and CD, respectively. The estimated prevalences of CD, UC, atypical UC, and IBDU in the Korean population were 69.5%, 9.4%, 8.0%, and 13.1%, respectively.</p><p><strong>Conclusion: </strong>This study is the first in Korea to estimate the prevalence of pediatric IBDU. This prevalence (13.1%) aligns with findings from Western studies. Large-scale prospective multicenter studies on PIBDU are required to examine the clinical features and outcomes of this condition.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254648/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. 非酒精性脂肪性肝炎肥胖儿童肝纤维化的血清学生物标志物
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.236
Jung Yeon Joo, In Hyuk Yoo, Hye Ran Yang

Purpose: The prevalence of nonalcoholic steatohepatitis (NASH) is increasing with the increasing prevalence of childhood obesity. Although NASH has a high risk of progression to liver fibrosis and cirrhosis, few studies have reported noninvasive markers for predicting hepatic fibrosis in children. This study aimed to evaluate and compare the diagnostic accuracies of serologic biomarkers and scoring systems for hepatic fibrosis in obese children with NASH.

Methods: A total of 96 children were diagnosed with NASH based on liver biopsy findings and divided into two groups according to the degree of liver fibrosis: mild (stage 0-1) or advanced (stage 2-4). Clinical and laboratory parameters and serum levels of hyaluronic acid and type IV collagen were measured. The aspartate aminotransferase/platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were calculated.

Results: Among the noninvasive markers, only serum type IV collagen level and FIB-4 were significantly different between the two groups. The area under the receiver operating curve of each biomarker and scoring system was 0.80 (95% confidence interval [CI]: 0.70-0.90) for type IV collagen at an optimal cutoff of 148 ng/mL (sensitivity 69.8%, specificity 84.6%), followed by 0.69 (95% CI: 0.57-0.83) for APRI, 0.68 (95% CI: 0.56-0.80) for FIB-4, and 0.65 (95% CI: 0.53-0.77) for hyaluronic acid.

Conclusion: Type IV collagen as a single noninvasive serologic biomarker for hepatic fibrosis and FIB-4 as a hepatic fibrosis score are beneficial in predicting advanced hepatic fibrosis and determining proper diagnosis and treatment strategies before fibrosis progresses in obese children with NASH.

目的:随着儿童肥胖症发病率的增加,非酒精性脂肪性肝炎(NASH)的发病率也在增加。虽然非酒精性脂肪性肝炎发展为肝纤维化和肝硬化的风险很高,但很少有研究报道预测儿童肝纤维化的非侵入性标记物。本研究旨在评估和比较肥胖儿童 NASH 患者肝纤维化的血清学生物标志物和评分系统的诊断准确性:共有96名儿童根据肝活检结果被诊断为NASH,并根据肝纤维化程度分为两组:轻度(0-1期)或晚期(2-4期)。测量了临床和实验室参数以及血清中透明质酸和 IV 型胶原蛋白的水平。计算天门冬氨酸氨基转移酶/血小板比率指数(APRI)和纤维化-4(FIB-4)评分:结果:在非侵入性指标中,只有血清 IV 型胶原蛋白水平和 FIB-4 在两组间存在显著差异。在最佳临界值为 148 ng/mL 时,IV 型胶原蛋白的接收器工作曲线下面积为 0.80(95% 置信区间 [CI]:0.70-0.90)(灵敏度为 69.8%,特异性为 84.6%),其次是 APRI 为 0.69(95% CI:0.57-0.83),FIB-4 为 0.68(95% CI:0.56-0.80),透明质酸为 0.65(95% CI:0.53-0.77):结论:IV型胶原作为肝纤维化的单一无创血清学生物标志物,FIB-4作为肝纤维化评分,有助于预测晚期肝纤维化,并在肥胖儿童NASH患者纤维化进展之前确定正确的诊断和治疗策略。
{"title":"Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.","authors":"Jung Yeon Joo, In Hyuk Yoo, Hye Ran Yang","doi":"10.5223/pghn.2024.27.4.236","DOIUrl":"10.5223/pghn.2024.27.4.236","url":null,"abstract":"<p><strong>Purpose: </strong>The prevalence of nonalcoholic steatohepatitis (NASH) is increasing with the increasing prevalence of childhood obesity. Although NASH has a high risk of progression to liver fibrosis and cirrhosis, few studies have reported noninvasive markers for predicting hepatic fibrosis in children. This study aimed to evaluate and compare the diagnostic accuracies of serologic biomarkers and scoring systems for hepatic fibrosis in obese children with NASH.</p><p><strong>Methods: </strong>A total of 96 children were diagnosed with NASH based on liver biopsy findings and divided into two groups according to the degree of liver fibrosis: mild (stage 0-1) or advanced (stage 2-4). Clinical and laboratory parameters and serum levels of hyaluronic acid and type IV collagen were measured. The aspartate aminotransferase/platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were calculated.</p><p><strong>Results: </strong>Among the noninvasive markers, only serum type IV collagen level and FIB-4 were significantly different between the two groups. The area under the receiver operating curve of each biomarker and scoring system was 0.80 (95% confidence interval [CI]: 0.70-0.90) for type IV collagen at an optimal cutoff of 148 ng/mL (sensitivity 69.8%, specificity 84.6%), followed by 0.69 (95% CI: 0.57-0.83) for APRI, 0.68 (95% CI: 0.56-0.80) for FIB-4, and 0.65 (95% CI: 0.53-0.77) for hyaluronic acid.</p><p><strong>Conclusion: </strong>Type IV collagen as a single noninvasive serologic biomarker for hepatic fibrosis and FIB-4 as a hepatic fibrosis score are beneficial in predicting advanced hepatic fibrosis and determining proper diagnosis and treatment strategies before fibrosis progresses in obese children with NASH.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Transfusion-Related Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study. 小儿白血病幸存者输血相关铁超载与肝纤维化之间的关系:一项横断面研究
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.215
Mahsa Sobhani, Naser Honar, Mohammadreza Fattahi, Sezaneh Haghpanah, Nader Shakibazad, Mohammadreza Bordbar

Purpose: Patients who receive frequent blood transfusions are at an elevated risk of developing hepatic fibrosis due to iron overload in the liver. In this study, we evaluated the effectiveness of transient elastography (TE) (FibroScan®) for assessing liver fibrosis in patients with pediatric cancer.

Methods: We enrolled 106 consecutive cases of acute leukemia in individuals under 21 years of age. The participants were followed for 2 years. Based on their serum ferritin (SF) levels, the patients were divided into two groups: group 1 (SF≥300 ng/mL) and group 2 (SF<300 ng/mL). A liver FibroScan® was performed, and a p-value of less than 0.05 was considered statistically significant.

Results: Among the various parameters in the liver function test (LFT), alkaline phosphatase was significantly higher in a subgroup of patients aged 5-8 years in group 2 compared to those in group 1. The indices of liver fibrosis determined by TE, including the FibroScan score, controlled attenuation parameter score, steatosis percentage, and meta-analysis of histological data in viral hepatitis score, as well as indirect serum markers of liver fibrosis such as the aminotransferase (AST)/alanine aminotransferase (ALT) ratio, Fibrosis 4 score, and AST to platelet ratio index, did not differ significantly between the two groups. The association between the TE results and LFT parameters was only significant for ALT.

Conclusion: Transfusion-associated iron overload does not have a significant correlation with severe liver fibrosis. FibroScan® is not a sensitive tool for detecting early stages of fibrosis in survivors of pediatric leukemia.

目的:经常接受输血的患者因肝脏铁负荷过重而发生肝纤维化的风险较高。在这项研究中,我们评估了瞬态弹性成像(TE)(FibroScan®)在评估儿童癌症患者肝纤维化方面的有效性:我们连续招募了 106 例 21 岁以下的急性白血病患者。我们对这些患者进行了为期两年的随访。根据血清铁蛋白(SF)水平将患者分为两组:第一组(SF≥300 ng/mL)和第二组(SF®进行检测,P值小于0.05为具有统计学意义:结果:在肝功能检测(LFT)的各项指标中,第 2 组 5-8 岁亚组患者的碱性磷酸酶明显高于第 1 组。通过 TE 确定的肝纤维化指标,包括 FibroScan 评分、受控衰减参数评分、脂肪变性百分比和病毒性肝炎组织学数据荟萃分析评分,以及肝纤维化的间接血清指标,如转氨酶(AST)/丙氨酸氨基转移酶(ALT)比值、纤维化 4 评分和 AST 与血小板比值指数,在两组之间没有显著差异。TE结果与LFT参数之间的关联仅对ALT有显著影响:结论:输血相关铁超载与严重肝纤维化无明显相关性。FibroScan® 并非检测小儿白血病幸存者早期肝纤维化的灵敏工具。
{"title":"Association between Transfusion-Related Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study.","authors":"Mahsa Sobhani, Naser Honar, Mohammadreza Fattahi, Sezaneh Haghpanah, Nader Shakibazad, Mohammadreza Bordbar","doi":"10.5223/pghn.2024.27.4.215","DOIUrl":"10.5223/pghn.2024.27.4.215","url":null,"abstract":"<p><strong>Purpose: </strong>Patients who receive frequent blood transfusions are at an elevated risk of developing hepatic fibrosis due to iron overload in the liver. In this study, we evaluated the effectiveness of transient elastography (TE) (FibroScan<sup>®</sup>) for assessing liver fibrosis in patients with pediatric cancer.</p><p><strong>Methods: </strong>We enrolled 106 consecutive cases of acute leukemia in individuals under 21 years of age. The participants were followed for 2 years. Based on their serum ferritin (SF) levels, the patients were divided into two groups: group 1 (SF≥300 ng/mL) and group 2 (SF<300 ng/mL). A liver FibroScan<sup>®</sup> was performed, and a <i>p</i>-value of less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Among the various parameters in the liver function test (LFT), alkaline phosphatase was significantly higher in a subgroup of patients aged 5-8 years in group 2 compared to those in group 1. The indices of liver fibrosis determined by TE, including the FibroScan score, controlled attenuation parameter score, steatosis percentage, and meta-analysis of histological data in viral hepatitis score, as well as indirect serum markers of liver fibrosis such as the aminotransferase (AST)/alanine aminotransferase (ALT) ratio, Fibrosis 4 score, and AST to platelet ratio index, did not differ significantly between the two groups. The association between the TE results and LFT parameters was only significant for ALT.</p><p><strong>Conclusion: </strong>Transfusion-associated iron overload does not have a significant correlation with severe liver fibrosis. FibroScan<sup>®</sup> is not a sensitive tool for detecting early stages of fibrosis in survivors of pediatric leukemia.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and Risks of Preprepared Parenteral Nutrition for Early Amino Acid Administration in Premature Infants with Very Low Birth Weight. 为出生体重极低的早产儿早期摄入氨基酸提供预制肠外营养的益处和风险。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.246
Pin-Chun Chen, Hsin-Chung Huang, Mei-Jy Jeng, Feng-Shiang Cheng

Purpose: Administering early parenteral amino acids to very low birth weight (VLBW) premature infants (birth body weight [BBW]<1,500 g) is challenging due to factors such as holidays, cost, and access to sterile compounding facilities. Using advance-prepared parenteral nutrition (PN) may address this issue and should be evaluated for its safety and potential benefits.

Methods: We extracted data from medical records collected between July 2015 and August 2019. VLBW infants received PN for at least seven days and were split into two groups: the traditional group (n=30), which initially received a glucose solution and then PN on workdays, and the pre-preparation group (n=16), which received advance-prepared PN immediately upon admission to the neonatal intensive care unit.

Results: The median BBWs of the traditional and pre-preparation groups were 1,180.0 vs. 1,210.0 g. In the initial two days, the pre-preparation group had a significantly higher amino acid intake (2.23 and 2.24 g/kg/d) than the traditional group (0 and 1.78 g/kg/d). The pre-preparation group exhibited greater head circumference growth ratio relative to birth (7th day: 1.21% vs. -3.57%, p=0.014; 21st day: 7.71% vs. 3.31%, p=0.017). No significant differences in metabolic tolerance were observed.

Conclusion: Advanced preparation of PN can be safely implemented in VLBW preterm infants, offering advantages such as early, higher amino acid intake and improved head circumference growth within the first 21 days post-birth. This strategy may serve as a viable alternative in settings where immediate provision of sterile compounding facilities is challenging.

目的:对极低出生体重(VLBW)早产儿(出生体重[BBW])使用早期肠外氨基酸的方法:我们从2015年7月至2019年8月期间收集的医疗记录中提取了数据。VLBW婴儿接受PN至少7天,分为两组:传统组(n=30),最初接受葡萄糖溶液,然后在工作日接受PN;预处理组(n=16),在进入新生儿重症监护室后立即接受提前预处理的PN:在最初两天,预处理组的氨基酸摄入量(2.23 和 2.24 克/千克/天)明显高于传统组(0 和 1.78 克/千克/天)。与出生时相比,预处理组的头围增长比率更大(第 7 天:1.21% 对 -3.57%,p=0.014;第 21 天:7.71% 对 3.31%,p=0.017)。代谢耐受性无明显差异:可以安全地为 VLBW 早产儿提前准备 PN,这样做的好处是可以在出生后的头 21 天内尽早摄入更多的氨基酸并改善头围的生长。在难以立即提供无菌配制设施的情况下,这一策略可作为一种可行的替代方案。
{"title":"Benefits and Risks of Preprepared Parenteral Nutrition for Early Amino Acid Administration in Premature Infants with Very Low Birth Weight.","authors":"Pin-Chun Chen, Hsin-Chung Huang, Mei-Jy Jeng, Feng-Shiang Cheng","doi":"10.5223/pghn.2024.27.4.246","DOIUrl":"10.5223/pghn.2024.27.4.246","url":null,"abstract":"<p><strong>Purpose: </strong>Administering early parenteral amino acids to very low birth weight (VLBW) premature infants (birth body weight [BBW]<1,500 g) is challenging due to factors such as holidays, cost, and access to sterile compounding facilities. Using advance-prepared parenteral nutrition (PN) may address this issue and should be evaluated for its safety and potential benefits.</p><p><strong>Methods: </strong>We extracted data from medical records collected between July 2015 and August 2019. VLBW infants received PN for at least seven days and were split into two groups: the traditional group (n=30), which initially received a glucose solution and then PN on workdays, and the pre-preparation group (n=16), which received advance-prepared PN immediately upon admission to the neonatal intensive care unit.</p><p><strong>Results: </strong>The median BBWs of the traditional and pre-preparation groups were 1,180.0 vs. 1,210.0 g. In the initial two days, the pre-preparation group had a significantly higher amino acid intake (2.23 and 2.24 g/kg/d) than the traditional group (0 and 1.78 g/kg/d). The pre-preparation group exhibited greater head circumference growth ratio relative to birth (7th day: 1.21% vs. -3.57%, <i>p</i>=0.014; 21st day: 7.71% vs. 3.31%, <i>p</i>=0.017). No significant differences in metabolic tolerance were observed.</p><p><strong>Conclusion: </strong>Advanced preparation of PN can be safely implemented in VLBW preterm infants, offering advantages such as early, higher amino acid intake and improved head circumference growth within the first 21 days post-birth. This strategy may serve as a viable alternative in settings where immediate provision of sterile compounding facilities is challenging.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254649/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time is Gut. Approaching Intestinal Leiomyositis: Case Presentation and Literature Review. 时间就是肠道走近肠道骨髓炎:病例介绍与文献综述。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.197
Michail Aftzoglou, Christina Heinrich, Till Sebastian Clauditz, Thomas Menter, Deborah Dorth, Konrad Reinshagen, Ingo Königs

T-lymphocytic intestinal leiomyositis is a rare cause of "pediatric intestinal pseudo-obstructions." Diagnosis may be difficult and requires full-thickness bowel biopsies during laparotomy or laparoscopy with possible enterostomy. Currently, immunosuppressive therapy is the only available treatment. A delay in diagnosis and therapy may negatively affect the prognosis because of ongoing fibrotic alterations; therefore, early diagnosis and consequent treatment are crucial. This review summarizes the available information on the nosology, diagnostic steps, and treatment modalities. Here, we report the youngest case of enteric leiomyositis reported in the last two decades and analyze its management by reviewing previous cases.

T淋巴细胞性肠利肌炎是导致 "小儿肠假性梗阻 "的一种罕见病因。诊断可能比较困难,需要在开腹手术或腹腔镜手术中进行全厚肠活检,并可能进行肠造口术。目前,免疫抑制疗法是唯一可用的治疗方法。由于纤维化改变仍在继续,延误诊断和治疗可能会对预后产生负面影响;因此,早期诊断和随之而来的治疗至关重要。本综述总结了有关该病的命名、诊断步骤和治疗方法的现有信息。在此,我们报告了过去二十年中最年轻的一例肠道利肌炎病例,并通过回顾以往病例分析了该病的治疗方法。
{"title":"Time is Gut. Approaching Intestinal Leiomyositis: Case Presentation and Literature Review.","authors":"Michail Aftzoglou, Christina Heinrich, Till Sebastian Clauditz, Thomas Menter, Deborah Dorth, Konrad Reinshagen, Ingo Königs","doi":"10.5223/pghn.2024.27.4.197","DOIUrl":"10.5223/pghn.2024.27.4.197","url":null,"abstract":"<p><p>T-lymphocytic intestinal leiomyositis is a rare cause of \"pediatric intestinal pseudo-obstructions.\" Diagnosis may be difficult and requires full-thickness bowel biopsies during laparotomy or laparoscopy with possible enterostomy. Currently, immunosuppressive therapy is the only available treatment. A delay in diagnosis and therapy may negatively affect the prognosis because of ongoing fibrotic alterations; therefore, early diagnosis and consequent treatment are crucial. This review summarizes the available information on the nosology, diagnostic steps, and treatment modalities. Here, we report the youngest case of enteric leiomyositis reported in the last two decades and analyze its management by reviewing previous cases.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Pediatric Endoscopy Training Situation in the Asia-Pacific Region: A Collaborative Survey by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition Endoscopy Scientific Subcommittee. 亚太地区儿科内镜培训现状:亚洲泛太平洋小儿胃肠病学、肝病学和营养学学会内镜科学小组委员会合作调查。
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.258
Nuthapong Ukarapol, Narumon Tanatip, Ajay Sharma, Maribel Vitug-Sales, Robert Nicholas Lopez, Rohan Malik, Ruey Terng Ng, Shuichiro Umetsu, Songpon Getsuwan, Tak Yau Stephen Lui, Yao-Jong Yang, Yeoun Joo Lee, Katsuhiro Arai, Kyung Mo Kim

Purpose: To date, there is no region-specific guideline for pediatric endoscopy training. This study aimed to illustrate the current status of pediatric endoscopy training in Asia-Pacific region and identify opportunities for improvement.

Methods: A cross-sectional survey, using a standardized electronic questionnaire, was conducted among medical schools in the Asia-Pacific region in January 2024.

Results: A total of 57 medical centers in 12 countries offering formal Pediatric Gastroenterology training programs participated in this regional survey. More than 75% of the centers had an average case load of <10 cases per week for both diagnostic and therapeutic endoscopies. Only 36% of the study programs employed competency-based outcomes for program development, whereas nearly half (48%) used volume-based curricula. Foreign body retrieval, polypectomy, percutaneous endoscopic gastrostomy, and esophageal variceal hemostasis, that is, sclerotherapy or band ligation (endoscopic variceal sclerotherapy and endoscopic variceal ligation), comprised the top four priorities that the trainees should acquire in the autonomous stage (unconscious) of competence. Regarding the learning environment, only 31.5% provided formal hands-on workshops/simulation training. The direct observation of procedural skills was the most commonly used assessment method. The application of a quality assurance (QA) system in both educational and patient care (Pediatric Endoscopy Quality Improvement Network) aspects was present in only 28% and 17% of the centers, respectively.

Conclusion: Compared with Western academic societies, the limited availability of cases remains a major concern. To close this gap, simulation and adult endoscopy training are essential. The implementation of reliable and valid assessment tools and QA systems can lead to significant development in future programs.

目的:迄今为止,还没有针对特定地区的儿科内镜培训指南。本研究旨在说明亚太地区儿科内镜培训的现状,并找出改进的机会:方法:2024 年 1 月,使用标准化电子问卷对亚太地区的医学院校进行了横断面调查:共有 12 个国家的 57 家提供正规小儿胃肠病学培训项目的医疗中心参与了此次地区调查。超过 75% 的中心平均病例数为结案数:与西方学术界相比,病例数量有限仍是一个主要问题。要缩小这一差距,模拟和成人内镜培训至关重要。实施可靠有效的评估工具和质量保证系统可促进未来项目的重大发展。
{"title":"Current Pediatric Endoscopy Training Situation in the Asia-Pacific Region: A Collaborative Survey by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition Endoscopy Scientific Subcommittee.","authors":"Nuthapong Ukarapol, Narumon Tanatip, Ajay Sharma, Maribel Vitug-Sales, Robert Nicholas Lopez, Rohan Malik, Ruey Terng Ng, Shuichiro Umetsu, Songpon Getsuwan, Tak Yau Stephen Lui, Yao-Jong Yang, Yeoun Joo Lee, Katsuhiro Arai, Kyung Mo Kim","doi":"10.5223/pghn.2024.27.4.258","DOIUrl":"10.5223/pghn.2024.27.4.258","url":null,"abstract":"<p><strong>Purpose: </strong>To date, there is no region-specific guideline for pediatric endoscopy training. This study aimed to illustrate the current status of pediatric endoscopy training in Asia-Pacific region and identify opportunities for improvement.</p><p><strong>Methods: </strong>A cross-sectional survey, using a standardized electronic questionnaire, was conducted among medical schools in the Asia-Pacific region in January 2024.</p><p><strong>Results: </strong>A total of 57 medical centers in 12 countries offering formal Pediatric Gastroenterology training programs participated in this regional survey. More than 75% of the centers had an average case load of <10 cases per week for both diagnostic and therapeutic endoscopies. Only 36% of the study programs employed competency-based outcomes for program development, whereas nearly half (48%) used volume-based curricula. Foreign body retrieval, polypectomy, percutaneous endoscopic gastrostomy, and esophageal variceal hemostasis, that is, sclerotherapy or band ligation (endoscopic variceal sclerotherapy and endoscopic variceal ligation), comprised the top four priorities that the trainees should acquire in the autonomous stage (unconscious) of competence. Regarding the learning environment, only 31.5% provided formal hands-on workshops/simulation training. The direct observation of procedural skills was the most commonly used assessment method. The application of a quality assurance (QA) system in both educational and patient care (Pediatric Endoscopy Quality Improvement Network) aspects was present in only 28% and 17% of the centers, respectively.</p><p><strong>Conclusion: </strong>Compared with Western academic societies, the limited availability of cases remains a major concern. To close this gap, simulation and adult endoscopy training are essential. The implementation of reliable and valid assessment tools and QA systems can lead to significant development in future programs.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary Atresia. 胆道闭锁婴儿接受卡萨伊手术长期疗效的综合预测因素
IF 1.3 Q3 PEDIATRICS Pub Date : 2024-07-01 Epub Date: 2024-07-08 DOI: 10.5223/pghn.2024.27.4.224
Anna Degtyareva, Medan Isaeva, Elena Tumanova, Elena Filippova, Anna Sugak, Alexander Razumovsky, Nadezhda Kulikova, Marina Albegova, Denis Rebrikov

Purpose: Biliary atresia (BA) is the leading cause of neonatal cholestasis (25-45%). The primary treatment is hepatic portoenterostomy (Kasai procedure), but only 20-40% provide long-term benefits. This study aimed to develop a predictive model for surgical efficacy by comparing preoperative and early postoperative indicators in infants with different outcomes.

Methods: We enrolled 166 infants with BA (93 girls, 73 boys) who underwent the Kasai procedure between September 2002 and December 2021, dividing them into favorable or adverse outcome groups. Over 40 parameters were measured, and the diagnostic significance of the prognostic model was evaluated.

Results: Kasai surgery was efficacious in 69 patients (42%) and non-efficacious in 97 (58%). Our model assesses efficacy by day 14 after surgery, improving on the <34 µmol/L direct bilirubin threshold established for 3-6 months after the procedure. Including the Desmet fibrosis score refined the model.

Conclusion: Blood cholesterol below 5.41 mmol/L, direct bilirubin below 56.3 µmol/L on postoperative days 14±3, and a low Desmet score indicate a high probability of efficacious Kasai surgery in infants with BA.

目的:胆道闭锁(BA)是新生儿胆汁淤积症的主要原因(25%-45%)。主要治疗方法是肝门肠管造口术(葛西手术),但只有20%-40%的患者能长期获益。本研究旨在通过比较不同结果婴儿的术前和术后早期指标,建立手术疗效预测模型:我们招募了 166 名在 2002 年 9 月至 2021 年 12 月期间接受 Kasai 手术的 BA 婴儿(93 名女孩,73 名男孩),并将他们分为结果良好组和结果不良组。我们测量了40多个参数,并评估了预后模型的诊断意义:69名患者(42%)接受了开塞手术,97名患者(58%)未接受开塞手术。我们的模型对术后第 14 天的疗效进行了评估,对结论进行了改进:术后第 14±3 天,血胆固醇低于 5.41 mmol/L,直接胆红素低于 56.3 µmol/L,且 Desmet 评分较低,表明 BA 婴儿接受 Kasai 手术的有效概率较高。
{"title":"Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary Atresia.","authors":"Anna Degtyareva, Medan Isaeva, Elena Tumanova, Elena Filippova, Anna Sugak, Alexander Razumovsky, Nadezhda Kulikova, Marina Albegova, Denis Rebrikov","doi":"10.5223/pghn.2024.27.4.224","DOIUrl":"10.5223/pghn.2024.27.4.224","url":null,"abstract":"<p><strong>Purpose: </strong>Biliary atresia (BA) is the leading cause of neonatal cholestasis (25-45%). The primary treatment is hepatic portoenterostomy (Kasai procedure), but only 20-40% provide long-term benefits. This study aimed to develop a predictive model for surgical efficacy by comparing preoperative and early postoperative indicators in infants with different outcomes.</p><p><strong>Methods: </strong>We enrolled 166 infants with BA (93 girls, 73 boys) who underwent the Kasai procedure between September 2002 and December 2021, dividing them into favorable or adverse outcome groups. Over 40 parameters were measured, and the diagnostic significance of the prognostic model was evaluated.</p><p><strong>Results: </strong>Kasai surgery was efficacious in 69 patients (42%) and non-efficacious in 97 (58%). Our model assesses efficacy by day 14 after surgery, improving on the <34 µmol/L direct bilirubin threshold established for 3-6 months after the procedure. Including the Desmet fibrosis score refined the model.</p><p><strong>Conclusion: </strong>Blood cholesterol below 5.41 mmol/L, direct bilirubin below 56.3 µmol/L on postoperative days 14±3, and a low Desmet score indicate a high probability of efficacious Kasai surgery in infants with BA.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lived Experiences of Parents of Children with Celiac Disease: A Descriptive Qualitative Study. 乳糜泻患儿父母的生活经历:描述性定性研究。
IF 1.9 Q2 Medicine Pub Date : 2024-05-01 Epub Date: 2024-05-07 DOI: 10.5223/pghn.2024.27.3.146
Nesibe S Kutahyalioglu, Gamze Kaş Alay

Purpose: Celiac disease (CD) is one of the most prevalent food-related illnesses in children, with a global prevalence of approximately 1.4%. CD can create an emotional burden, particularly on mothers, who are mainly responsible for managing challenges related to adherence to a gluten-free diet, high food costs, and food problems in schools and social areas. There is a gap in the literature, and parental experiences of raising children with CD should be explicitly examined. This qualitative study sought to provide insights into the experiences of parents raising a child with CD in the Turkish context.

Methods: This study used a descriptive qualitative research methodology and conducted individual semi-structured video-based dyadic interviews with 19 parents.

Results: Participants experienced both challenges and motivators through management of their children's CD. Analyses of the interview transcripts through the data uncovered three main themes focusing primarily on parental concerns: (1) parental challenges in child's disease management, (2) supportive care needs, and (3) parental expectations.

Conclusion: A multidisciplinary team should approach the child and family immediately after diagnosis, and facilities should support parents with continuing education and psychological, financial, and social assistance.

目的:乳糜泻(CD)是最常见的儿童食物相关疾病之一,全球发病率约为 1.4%。乳糜泻可造成精神负担,尤其是对母亲而言,她们主要负责应对与坚持无麸质饮食、高昂的食品成本以及学校和社交场所的食品问题有关的挑战。这方面的文献尚属空白,应明确研究父母抚养 CD 患儿的经历。本定性研究旨在深入了解土耳其父母抚养 CD 患儿的经历:本研究采用描述性定性研究方法,对 19 位父母进行了个人半结构化视频双向访谈:结果:参与者在管理其子女 CD 的过程中既经历了挑战,也获得了动力。通过对访谈记录的数据分析,发现了三个主要的主题,主要集中在家长关注的问题上:(1)家长在儿童疾病管理中面临的挑战,(2)支持性护理需求,以及(3)家长的期望:结论:确诊后,多学科团队应立即与患儿及家庭联系,医疗机构应为家长提供继续教育以及心理、经济和社会援助。
{"title":"Lived Experiences of Parents of Children with Celiac Disease: A Descriptive Qualitative Study.","authors":"Nesibe S Kutahyalioglu, Gamze Kaş Alay","doi":"10.5223/pghn.2024.27.3.146","DOIUrl":"10.5223/pghn.2024.27.3.146","url":null,"abstract":"<p><strong>Purpose: </strong>Celiac disease (CD) is one of the most prevalent food-related illnesses in children, with a global prevalence of approximately 1.4%. CD can create an emotional burden, particularly on mothers, who are mainly responsible for managing challenges related to adherence to a gluten-free diet, high food costs, and food problems in schools and social areas. There is a gap in the literature, and parental experiences of raising children with CD should be explicitly examined. This qualitative study sought to provide insights into the experiences of parents raising a child with CD in the Turkish context.</p><p><strong>Methods: </strong>This study used a descriptive qualitative research methodology and conducted individual semi-structured video-based dyadic interviews with 19 parents.</p><p><strong>Results: </strong>Participants experienced both challenges and motivators through management of their children's CD. Analyses of the interview transcripts through the data uncovered three main themes focusing primarily on parental concerns: (1) parental challenges in child's disease management, (2) supportive care needs, and (3) parental expectations.</p><p><strong>Conclusion: </strong>A multidisciplinary team should approach the child and family immediately after diagnosis, and facilities should support parents with continuing education and psychological, financial, and social assistance.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11134180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Associated Factors of Vertebral Fractures in Children with Chronic Liver Disease with and without Liver Transplantation. 接受或未接受肝移植的慢性肝病患儿椎体骨折的发生率及相关因素。
IF 1.9 Q2 Medicine Pub Date : 2024-05-01 Epub Date: 2024-05-07 DOI: 10.5223/pghn.2024.27.3.158
Wittayathorn Pornsiripratharn, Suporn Treepongkaruna, Phatthawit Tangkittithaworn, Niyata Chitrapaz, Chatmanee Lertudomphonwanit, Songpon Getsuwan, Pornthep Tanpowpong, Pat Mahachoklertwattana

Purpose: To evaluate the prevalence of vertebral fracture (VF) in children with chronic liver disease (CLD) with and without liver transplantation (LT) and to determine the associated factors.

Methods: A cross-sectional study was conducted. Patients aged 3-21 years with CLD both before and after LT were enrolled in the study. Lateral thoracolumbar spine radiographs were obtained and assessed for VF using Mäkitie's method. Clinical and biochemical data were collected.

Results: We enrolled 147 patients (80 females; median age 8.8 years [interquartile range 6.0-11.8]; 110 [74.8%] in the LT group and 37 [25.2%] in the non-LT group). VF was identified in 21 patients (14.3%): 17/110 (15.5%) in the LT group and 4/37 (10.8%) in the non-LT group (p=0.54). Back pain was noted in only three patients with VF. In the univariate analysis, a height z-score below -2.0 (p=0.010), pre-LT hepatopulmonary syndrome (p=0.014), elevated serum direct and total bilirubin levels (p=0.037 and p=0.049, respectively), and vitamin D deficiency at 1-year post-LT (p=0.048) were associated with VF in the LT group. In multivariate analysis, height z-score below -2.0 was the only significant associated factor (odds ratio, 5.94; 95% confidence interval, 1.49-23.76; p=0.012) for VF. All VFs in the non-LT group were reported in males.

Conclusion: In children with CLD, VF is common before and after LT. Most patients with VF are asymptomatic. Screening for VF should be considered in patients with a height z-score below -2.0 after LT.

目的:评估接受或未接受肝移植(LT)的慢性肝病(CLD)患儿椎体骨折(VF)的发生率,并确定相关因素:方法:进行了一项横断面研究。方法:这是一项横断面研究,研究对象为接受肝移植前后的 3-21 岁慢性肝病患者。研究人员拍摄了胸腰椎侧位X光片,并采用Mäkitie方法对VF进行了评估。研究还收集了临床和生化数据:我们共招募了 147 名患者(80 名女性;中位年龄为 8.8 岁[四分位间差为 6.0-11.8 岁];LT 组 110 人[74.8%],非 LT 组 37 人[25.2%])。21名患者(14.3%)发现了室颤:LT组为17/110(15.5%),非LT组为4/37(10.8%)(P=0.54)。只有三名 VF 患者出现背痛。在单变量分析中,身高 Z 值低于-2.0(p=0.010)、LT 前肝肺综合征(p=0.014)、血清直接胆红素和总胆红素水平升高(分别为 p=0.037 和 p=0.049)、LT 后 1 年维生素 D 缺乏(p=0.048)与 LT 组 VF 相关。在多变量分析中,身高 Z 值低于-2.0 是 VF 唯一显著的相关因素(几率比,5.94;95% 置信区间,1.49-23.76;p=0.012)。非LT组的所有VF均为男性:结论:在CLD患儿中,VF在LT前后都很常见。结论:在 CLD 儿童中,室颤在 LT 前后都很常见,大多数室颤患者都没有症状。LT后身高Z值低于-2.0的患者应考虑进行VF筛查。
{"title":"Prevalence and Associated Factors of Vertebral Fractures in Children with Chronic Liver Disease with and without Liver Transplantation.","authors":"Wittayathorn Pornsiripratharn, Suporn Treepongkaruna, Phatthawit Tangkittithaworn, Niyata Chitrapaz, Chatmanee Lertudomphonwanit, Songpon Getsuwan, Pornthep Tanpowpong, Pat Mahachoklertwattana","doi":"10.5223/pghn.2024.27.3.158","DOIUrl":"10.5223/pghn.2024.27.3.158","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the prevalence of vertebral fracture (VF) in children with chronic liver disease (CLD) with and without liver transplantation (LT) and to determine the associated factors.</p><p><strong>Methods: </strong>A cross-sectional study was conducted. Patients aged 3-21 years with CLD both before and after LT were enrolled in the study. Lateral thoracolumbar spine radiographs were obtained and assessed for VF using Mäkitie's method. Clinical and biochemical data were collected.</p><p><strong>Results: </strong>We enrolled 147 patients (80 females; median age 8.8 years [interquartile range 6.0-11.8]; 110 [74.8%] in the LT group and 37 [25.2%] in the non-LT group). VF was identified in 21 patients (14.3%): 17/110 (15.5%) in the LT group and 4/37 (10.8%) in the non-LT group (<i>p</i>=0.54). Back pain was noted in only three patients with VF. In the univariate analysis, a height z-score below -2.0 (<i>p</i>=0.010), pre-LT hepatopulmonary syndrome (<i>p</i>=0.014), elevated serum direct and total bilirubin levels (<i>p</i>=0.037 and <i>p</i>=0.049, respectively), and vitamin D deficiency at 1-year post-LT (<i>p</i>=0.048) were associated with VF in the LT group. In multivariate analysis, height z-score below -2.0 was the only significant associated factor (odds ratio, 5.94; 95% confidence interval, 1.49-23.76; <i>p</i>=0.012) for VF. All VFs in the non-LT group were reported in males.</p><p><strong>Conclusion: </strong>In children with CLD, VF is common before and after LT. Most patients with VF are asymptomatic. Screening for VF should be considered in patients with a height z-score below -2.0 after LT.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11134177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multicenter Pilot Study of Biliary Atresia Screening Using Digital Stool Color Imaging. 利用数字粪便彩色成像筛查胆道闭锁的多中心试点研究。
IF 1.9 Q2 Medicine Pub Date : 2024-05-01 Epub Date: 2024-05-07 DOI: 10.5223/pghn.2024.27.3.168
Kannamon Waitayagitgumjon, Wannisa Poocharoen, Suchin Trirongjitmoah, Kriengsak Treeprapin, Arada Suttiwongsing, Thetiya Wirifai, Chira Trirongchitmoh, Pitiporn Tangkabuanbutr

Purpose: The presence of alcoholic stool in biliary atresia (BA) patients is the basis of a stool color card (SCC), a screening tool that has led to more patients receiving Kasai portoenterostomy earlier. This study aimed to evaluate the color image processing of stool images captured using smartphones. We propose that measuring digital color parameters is a more objective method for identifying BA stools and may improve the sensitivity of BA screening.

Methods: A prospective study was conducted in five hospitals in Thailand between October 1, 2020, and December 31, 2021. Stools from infants presenting with jaundice, acholic stool, or dark-colored urine were photographed. Digital image color analysis was performed, and software was developed based on the color on the original SCC. Sensitivity and specificity for predicting BA stools were compared between the SCC and the software.

Results: Of 33 infants eligible for data collection, 19 were diagnosed with BA. Saturation and blue were two potential digital color parameters used to differentiate BA stools. The receiver operating characteristic curve was used to determine the optimum cutoff point of both values, and when saturation ≤56 or blue ≥61 was set as a threshold for detecting BA stool, high accuracy was achieved at 81.8% and 78.8%, respectively.

Conclusion: Digital image processing is a promising technology. With appropriate cutoff values of saturation in hue, saturation, value and blue in red, green, blue color models, BA stools can be identified, and equivocal-colored stools of non-BA patients can be differentiated with acceptable accuracy in infants presenting with jaundice.

目的:胆道闭锁(BA)患者出现的酒精粪便是粪便色卡(SCC)的基础,这种筛查工具使更多的患者提前接受了卡萨伊肠造口术。本研究旨在评估使用智能手机拍摄的粪便图像的色彩图像处理。我们认为,测量数字颜色参数是识别 BA 粪便的一种更客观的方法,可提高 BA 筛查的灵敏度:一项前瞻性研究于 2020 年 10 月 1 日至 2021 年 12 月 31 日在泰国的五家医院进行。对出现黄疸、无痛性粪便或深色尿液的婴儿粪便进行拍照。进行数字图像颜色分析,并根据原始 SCC 上的颜色开发软件。比较了 SCC 和软件预测 BA 便的灵敏度和特异性:结果:在符合数据收集条件的 33 名婴儿中,19 名被诊断为 BA。饱和度和蓝色是用于区分 BA 粪便的两个潜在数字颜色参数。当饱和度≤56或蓝色≥61被设定为检测BA粪便的阈值时,准确率分别达到81.8%和78.8%:结论:数字图像处理是一项前景广阔的技术。结论:数字图像处理技术是一项很有前途的技术,通过红、绿、蓝色彩模型中色调、饱和度、值和蓝色饱和度的适当临界值,可以识别 BA 粪便,并能以可接受的准确度区分非 BA 患者的等色粪便。
{"title":"A Multicenter Pilot Study of Biliary Atresia Screening Using Digital Stool Color Imaging.","authors":"Kannamon Waitayagitgumjon, Wannisa Poocharoen, Suchin Trirongjitmoah, Kriengsak Treeprapin, Arada Suttiwongsing, Thetiya Wirifai, Chira Trirongchitmoh, Pitiporn Tangkabuanbutr","doi":"10.5223/pghn.2024.27.3.168","DOIUrl":"10.5223/pghn.2024.27.3.168","url":null,"abstract":"<p><strong>Purpose: </strong>The presence of alcoholic stool in biliary atresia (BA) patients is the basis of a stool color card (SCC), a screening tool that has led to more patients receiving Kasai portoenterostomy earlier. This study aimed to evaluate the color image processing of stool images captured using smartphones. We propose that measuring digital color parameters is a more objective method for identifying BA stools and may improve the sensitivity of BA screening.</p><p><strong>Methods: </strong>A prospective study was conducted in five hospitals in Thailand between October 1, 2020, and December 31, 2021. Stools from infants presenting with jaundice, acholic stool, or dark-colored urine were photographed. Digital image color analysis was performed, and software was developed based on the color on the original SCC. Sensitivity and specificity for predicting BA stools were compared between the SCC and the software.</p><p><strong>Results: </strong>Of 33 infants eligible for data collection, 19 were diagnosed with BA. Saturation and blue were two potential digital color parameters used to differentiate BA stools. The receiver operating characteristic curve was used to determine the optimum cutoff point of both values, and when saturation ≤56 or blue ≥61 was set as a threshold for detecting BA stool, high accuracy was achieved at 81.8% and 78.8%, respectively.</p><p><strong>Conclusion: </strong>Digital image processing is a promising technology. With appropriate cutoff values of saturation in hue, saturation, value and blue in red, green, blue color models, BA stools can be identified, and equivocal-colored stools of non-BA patients can be differentiated with acceptable accuracy in infants presenting with jaundice.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11134179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Gastroenterology, Hepatology & Nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1